Abstract
Background
With the increasing incidence of breast cancer in patients over 70 years, there is interest in the best therapeutic approach.
Aims
To review the management of breast cancer in elderly women and to identify the factors involved in the decision to treat patients with tamoxifen as first line therapy.
Patients and methods
Between 1986 and 1999, 302 female patients aged ≥ 70 years presented with primary breast cancer, of whom 219 underwent surgery, 79 received tamoxifen as first line treatment and four received primary radiotherapy. A retrospective review was performed on these 79 patients and the outcome recorded.
Results
Of these 79 patients, data was available on 68. Follow-up ranged from one to 63 months (median 17 months). Co-morbidity was the principal reason for choosing first line tamoxifen therapy in 61% and patient preference in 11%. Tumour size was less than 5cm in 51%. In 25% tumour size decreased, in 24% it remained stable and in 27% it increased in size following tamoxifen therapy. Additional treatment was prescribed for 33% of patients.
Conclusion
In the authors’ experience, for those elderly patients suffering considerable co-morbidity or who refuse surgical intervention, tamoxifen is an acceptable alternative.
Similar content being viewed by others
References
Flemming ID, Fleming MD. Breast cancer in elderly women.Cancer Supplement 1991; 2160–4.
Jancik R, Ries LG, Yates JW. Breast cancer in ageing women: a population based study of contrast in stage, surgery and survival.Cancer 1989; 63: 976–81.
Jancik R, Ries L. Cancer in the aged: an epidemiological perspective on treatment issues.Cancer 1991; 68 (Suppl): 2493–510.
Adami H-O, Malker B, Holmberg L et al. The relation between survival and age at diagnosis in breast cancer.New Engl J Med 1986; 315: 559.
Gazet JC, Ford HT, Coombes RC et al. Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer.Eur J Surg Oncol 1994; 20: 207–14.
Amsterdam E, Birkenfield S, Gilad A, Krispin M. Surgery for carcinoma of the breast in women over 70 years of age.J Surg Oncol 1987; 35: 180–3.
Bates T, Riley DL, Houghton J, Fallowfield L, Baum M. Breast cancer in elderly women: A cancer research campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The elderly breast cancer working party.Br J Surg 1991; 78: 591–4.
Robertson JFR, Todd JH, Ellis IO, Elston CW, Blamey RW. Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer.Br Med J 1988; 297: 511–4.
Horobin JM, Preece PE, Dewar JR, Wood RA, Cushieri A. Longterm follow up of elderly patients with locoregional breast cancer treated with tamoxifen only.Br J Surg 1991; 78: 213–7.
Haagensen CD. Diseases of the breast. (2nd edition) Philadelphia: WB Saunders 1971; 658–60.
Davies SJ, Karrer WF, Moor BJ, Rose SG, Eakins G. Characteristics of breast cancer in women over 80 years of age.Am J Surg 1985; 150: 655–8.
Hunt KE, Fry DE, Bland KI. Breast carcinoma in the elderly patient: an assessment of operative risk, morbidity and mortality.Am J Surg 1980; 140: 339–42.
Ashkanani F, Eremin O, Heys SD. The management of cancer of the breast in the elderly.Eur J Surg Oncol 1998; 24: 396–402.
Satariano WA, Ragland DR. The effect of co-morbidity on 3-year survival of women with primary breast cancer.Ann Int Med 1994; 120: 104–10.
Gaskell DJ, Hawkins RA, Sangsterl K, Chetty U, Forrest APM. Relation between immunocytochemical estimation of oestrogen receptor in elderly patients with primary breast cancer in response to tamoxifen.Lancet 1989; i: 1044–6.
Heyderman E, Ebbs SR, Larkin SE et al. Response of breast carcinoma to endocrine therapy predicted using immunostained pelleted fine needle aspirates.Br J Cancer 1989; 60: 630–3.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hooper, S.B., Hill, A.D.K., Kennedy, S. et al. Tamoxifen as the primary treatment in elderly patients with breast cancer. Ir J Med Sci 171, 28–30 (2002). https://doi.org/10.1007/BF03168937
Issue Date:
DOI: https://doi.org/10.1007/BF03168937